80 related articles for article (PubMed ID: 2417462)
1. [Clinicopathological observation on renal cell carcinoma. "The relationship between the histological and clinical findings"].
Yoneda F; Tsujimura H; Kagawa S; Kurokawa K; Akagi G
Hinyokika Kiyo; 1985 Sep; 31(9):1525-9. PubMed ID: 2417462
[TBL] [Abstract][Full Text] [Related]
2. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.
Ito K; Yoshii H; Asakuma J; Sato A; Horiguchi A; Sumitomo M; Hayakawa M; Asano T
Jpn J Clin Oncol; 2009 Sep; 39(9):588-94. PubMed ID: 19556339
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in renal cell carcinoma].
Uchida T; Shinohara K; Kobayashi K; Honda N; Ao T; Omata T; Odajima K; Koshiba K
Hinyokika Kiyo; 1986 Jul; 32(7):929-40. PubMed ID: 3776772
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of renal cell carcinoma invading adjacent organs].
Ishikura K; Yoshida N; Hasegawa M; Nomura K; Okamoto T; Tanji S; Fujioka T; Ohhori T; Kubo T
Hinyokika Kiyo; 1994 May; 40(5):373-7. PubMed ID: 8023760
[TBL] [Abstract][Full Text] [Related]
6. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
[TBL] [Abstract][Full Text] [Related]
7. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of 55 cases of renal cell carcinoma].
Saito K; Iwamuro S; Fujii H; Kondo I
Hinyokika Kiyo; 1989 Nov; 35(11):1847-52. PubMed ID: 2618882
[TBL] [Abstract][Full Text] [Related]
9. [Influential clinical and pathological factors on prognosis of renal cell carcinoma].
Saika T; Yamamoto Y; Takeda K; Asahi T
Hinyokika Kiyo; 1994 Mar; 40(3):189-93. PubMed ID: 7513936
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on renal cell carcinoma].
Yoneda F; Nakajima M; Kagawa S; Kurokawa K
Hinyokika Kiyo; 1985 Apr; 31(4):585-94. PubMed ID: 2412420
[TBL] [Abstract][Full Text] [Related]
12. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
14. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
15. [Sedimentation rate and renal cancer].
Iversen OH; Røger M; Wetteland P; Solberg HE
Tidsskr Nor Laegeforen; 1997 Jun; 117(17):2493-6. PubMed ID: 9265313
[TBL] [Abstract][Full Text] [Related]
16. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
17. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma.
Sargin SY; Ekmekcioglu O; Arpali E; Altinel M; Voyvoda B
Urol Int; 2009; 82(3):324-9. PubMed ID: 19440022
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in renal cell carcinoma.
Eker R; Nesland JM; Andersen A; Johannessen JV
Histol Histopathol; 1986 Jul; 1(3):255-70. PubMed ID: 2980119
[TBL] [Abstract][Full Text] [Related]
19. [Tumor factors influencing the prognosis of renal cell carcinoma].
Igarashi T; Murakami S; Takahara M; Yamanishi T; Matsuzaki O
Hinyokika Kiyo; 1986 Jan; 32(1):1-10. PubMed ID: 3962801
[TBL] [Abstract][Full Text] [Related]
20. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
